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ABSTRACT
O bjective : In this study we investigated the value 
of Doppler ultrasonography (DUSG) in evaluating 
the endometrium of postmenopausal women 
receiving hormone replacement therapy (HRT).
Material and Method: Sixty-five postmenopausal 
women constituted the material of our study. 
Pelvic DUSG was used to evaluate endometrial 
thickness and resistance index (Rl) values before 
and after one year of hormone replacement 
therapy HRT. Forty-two patients completed the 
study and statistical analysis was performed 
using paired t-test and variables using multiple 
regression analysis.
R e su lts : Endometrial thickness was measured 
as 3.5(1.5 mm after one year of therapy. The 
increase in thickness was statistically significant 
(p<0.05)). Although there was a slight decrease 
in Rl values, this finding was not considered to be 
statistically significant (p>0.05).
C o n c lu s io n : In this study we concluded that 
uterine artery Rl does not change significantly 
after HRT; this conclusion contradicts other 
studies in the literature. This difference may be 
due to the short duration of menopause in our 
study group.
K e y  W o rd s : Doppler ultrasonography,
Menopause, HRT
INTRO DUCTION
Menopause is a milestone affecting women's 
health both physically and psychologically. 
Cultural and social attitudes and beliefs are 
important in the way a woman accepts this era (1 ).
The necessity of regular evaluation of the 
endometrium and breast in postmenopausal 
women using hormone replacement therapy 
(HRT) is universally acknowledged. Methods and 
intervals of evaluation are still controversial.
Doppler ultrasonography (DUSG) is an 
acceptable method in detecting gynaecological 
malignancies (2). Low vascular impedance due 
to angiogenesis in the tumor and high diastolic 
blood flow is typical for malignancies. However, 
diastolic blood flow is lowered and almost absent 
because of the atrophic endometrium and 
increased vascular impedence is present in the 
uterine artery in postmenopausal women (3,4).
In this study we aimed to investigate the effects 
of HRT on the endometrium and uterine artery 
perfusion.
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MATERIAL A N D  M ETHODS
Sixty-five healthy postmenopausal women with 
an age range 29-67 presenting to the 
Haydarpaşa Numune Hospital Outpatient 
Menopause Clinic constituted the material of our 
study. None had received HRT before and at 
least one year had passed after the onset of 
menopause.Criteria for inclusion in the study 
group were:1 ,FSH>40 IU/L,2.A minimum of one 
years' amennorhea, 3.E2<50 pg/ml.
Blood lipids, fasting glucose, liver and kidney 
function tests and hemogram were performed 
and mammography, bone mineral density, pelvic 
Doppler USG and pap-smears were evaluated in 
all women before starting HRT.
All women received oral estradiol valerat for 21 
days with cyproterone acetate for the last 10 
days in a cyclic-sequential regimen. 1g of oral 
calcium was added. Routine follow-ups were 
scheduled on the 3rd, 6th and 12th months.
Blood samples were checked on 3rd and 6th 
months and every parameter including pelvic 
Doppler USG was reevaluated at the end of the 
12th month.
Doppler USG was evaluated using a colour 
Doppler Toshiba Sonolayer SSA 270-A with a 7.5 
mHz transducer both before and after HRT. We 
assessed the resistance index (Rl) in the uterine 
artery. Endometrial thickness was measured 
from the thickest part of the longitudinal axis of 
the uterus. Control Doppler ultrasonographies 
were performed on the 20-21th days of the cycle.
Statistical analysis was performed using paired t- 
test and variables using multiple regression 
analysis.
RESULTS
Forty-two patients completed the study .The 
average age of the 42 patients was 51 and the 
average age of menopause was 48. The average 
duration of menopause was 4.4 years. The 
patients selected had not received HRT before.
The mean endometrial thickness measured 
using transvaginal Doppler ultrasonography
before HRT was found to be 3.5±2.1 mm. 
Endometrial biopsies were performed in 2 
patients with endometrial thicknesses >5 mm. 
Pathology reports of their samples showed 
inactive endometrium in both. The average 
uterine Rl values were 0.84±0.009 (Range 0.70-
1.00) in this group.
Endometrial thickness after one year of HRT was 
measured as 5.71±1.5 mm (Range 3.60-11.3 
mm) and mean uterine artery Rl values were 
0.7910.05 (Range 0.70-0.88).
By using multiple regression analysis to compare 
uterine artery Rl values with endometrium 
thickness, duration of menopause, and age, we 
found no correlation (p>0.05). The result was the- 
same for correlation analysis.
The increase in endometrial thickness after HRT 
was statistically significant (p<0.05). Although Rl 
values dropped after HRT this decrease was not 
considered to be statistically significant (p>0.05).
Endometrial biopsies were performed in 15 
patients with endometrial thickness >5 mm. After 
HRT pathology reports of these samples 
revealed inactive endometrium in 8, proliferative 
endometrium in 1 and secretory endometrium in 
6 patients.
A positive correlation existed between age and 
duration of menopause whereas duration of 
menopause and endometrial thickness showed 
negative correlation.
DISCUSSION
Evaluation of the endometrium using 
transvaginal ultrasonography before and during 
use of HRT is a commonly accepted method. 
Recently Doppler ultrasonography is used to 
detect endometrial pathologies (1,2,5).
In a study perfomed by Kurjak et al (6) the 
average Rl of postmenopausal women with 
duration of menopause between 1 to 5 years not 
receiving HRT was 0.89, whereas this value was 
0.94 for women with duration of menopause >16 
years. The mean Rl was 0.85 for women 
receiving HRT for 1 to 5 years and 0.83 for 
women receiving HRT for over 6 years. This
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study showed that Rl decreased as the duration 
of menopause increased.
Bonilla et al showed that the mean Rl fell to 
87%±4% of baseline values during the first 
month of therapy (7). Their findings suggested 
that the increase in vascular flow occurred even 
in women who began HRT long after 
menopause. Jakap stated that the positive 
vascular changes and increased peripheral 
perfusion in women taking HRT detected by 
Doppler ultrasonography are due to the 
vasodilatator effect of oestrogen leading to 
cardiovascular and cerebrovascular protection
(8). While studies show that sequential combined 
HRT lowers arterial impedence (9), the same 
effect is not seen in continuous HRT and Rl 
values are unchanged (10,11).However,Doren et 
al showed that continuous HRT did lower uterine 
Rl values(12).ln a study by Bekavac et al, 
analysis of uterine arteries flow velocities showed 
a significant positive correlation between Rl and 
years of menopause with a higher value for 
patients with longer menopause duration.After 
six months of HRT, plasma estradiol 
concentrations inversely correlated with Rl of 
uterine arteries. They concluded that Doppler 
studies of the uterine arteries could provide 
specific and precise pathophysiological 
information to assess blood flow variations in 
correlation with combined HRT (13).Kurjak et al's 
study also confirmed these findings and they 
concluded that uterine artery Rl does not change 
significantly in the first postmenopausal years 
thus supporting the thesis that the aging process 
initially affects the uterus less than the 
ovary.Furthermore, they also noted that proper 
hormonal stimulation could even delay this aging 
process (5).In our study we found that mean 
uterine artery Rl was 0.84 before HRT. This 
decreased to 0.79 after HRT but the difference 
was not considered to be statistically significant 
(p>0.05). This may be caused by the short 
duration of menopause of the patients in our 
study group.
Varner et al (14) studied 80 postmenopausal 
women and performed endometrial biopsies in 
20 patients with endometrium thickness of more 
than 4 mm and compared the pathological results 
with transvaginal sonographic scanning. They 
found proliferative, secretory or hyperplastic 
endometrium and in one case low-grade
carcinoma. We performed endometrial biopsies 
in 15 cases with endometrial thickness >5 mm 
and found inactive endometrium in 8, proliferative 
endometrium in 1 and secretory endometrium in 
6 of these patients.
In our study, mean endometrium thickness was 
3.5±2.1 mm before and 5.7±1.5 mm after a year 
of HRT. This increase was statistically significant 
(p<0.05). There was an inverse correlation 
between duration of menopause and endometrial 
thickness. This finding was congenial with the 
results of other authors (15-17).
Sheth et al (18) investigated if endometrial blood 
flow analysis could be used to differentiate 
between benign and malignant causes of 
endometrial thickening in postmenopausal 
women. They concluded that low-impedance 
arterial flow is observed in various diseases of 
the endometrium, but that there is an overlap 
between the Rl of benign and malignant lesions.
We concluded that although HRT lowers uterine 
artery Rl values slightly, the difference cannot be 
considered to be statistically significant. 
Transvaginal USG together with Doppler 
ultrasonography is useful in the evaluation of 
women receiving HRT and will reduce the 
number of invasive procedures performed.
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